Benjamin Wilkin

Benjamin Wilkin is product marketing manager at Crown Bioscience.

Articles by Benjamin Wilkin

Cancer detection and screening as a treatment for malignant cells with a biopsy or testing caused by carcinogens and genetics with a cancerous cell as an immunotherapy symbol | Image credit: © freshidea - © freshidea - stock.adobe.com

How Patient-Derived Models and Advanced Imaging Systems Are Shaping Next-Gen Immunotherapies

ByBenjamin Wilkin

April 6th 2026

CGT is rapidly transforming oncology and rare disease research, with patient-derived models, advanced imaging, CRISPR/Cas9, and 3D organoids driving innovation while solid tumor modeling remains a critical frontier.

Latest Updated Articles

How Patient-Derived Models and Advanced Imaging Systems Are Shaping Next-Gen Immunotherapies
April 6th 2026